Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,373 | -186 | -469 | -1,311 | -979 |
| Income taxes - deferred | -157 | -202 | N/A | N/A | N/A |
| Accounts receivable | N/A | 28 | -23 | N/A | 7,000 |
| Other Working Capital | 89 | -271 | -32 | 931 | 7,884 |
| Other Operating Activity | 0 | -28 | 23 | 0 | -7,000 |
| Operating Cash Flow | $1,305 | $-659 | $-501 | $-380 | $6,905 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 43,600 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -524 | N/A |
| Dividend Paid | -1,275 | N/A | N/A | N/A | -7,959 |
| Financing Cash Flow | $-1,275 | $N/A | $N/A | $43,076 | $-7,959 |
| Beginning Cash Position | 46,982 | 47,641 | 48,142 | 5,446 | 6,500 |
| End Cash Position | 47,012 | 46,982 | 47,641 | 48,142 | 5,446 |
| Net Cash Flow | $30 | $-659 | $-501 | $42,696 | $-1,054 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,305 | -659 | -501 | -380 | 6,905 |
| Free Cash Flow | 1,305 | -659 | -501 | -380 | 6,905 |